NCT01935869View on ClinicalTrials.gov

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

PHASE1CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100

DRUG

Vehicle

DRUG

Petrolatum ointment

Trial Locations (1)

06202

CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Hôpital de l'Archet 2, Nice

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01935869 - Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100 | Biotech Hunter | Biotech Hunter